Huang, Chung-Feng
Iio, Etsuko
Jun, Dae Won
Ogawa, Eiichi
Toyoda, Hidenori
Hsu, Yao-Chun
Haga, Hiroaki
Iwane, Shinji
Enomoto, Masaru
Lee, Dong Hyun
Wong, Grace
Liu, Chen-Hua
Tada, Toshifumi
Chuang, Wan-Long
Cheung, Ramsey
Hayashi, Jun
Tseng, Cheng-Hao
Yasuda, Satoshi
Tran, Sally
Kam, Leslie
Henry, Linda
Jeong, Jae Yoon
Nomura, Hideyuki
Park, Seung Ha
Nakamuta, Makoto
Huang, Jee-Fu
Tai, Chi-Ming
Lo, Gin-Ho
Lee, Mei-Hsuan
Yang, Hwai-I
Kao, Jia-Horng
Tamori, Akihiro
Eguchi, Yuichiro
Ueno, Yoshiyuki
Furusyo, Norihiro
Tanaka, Yasuhito
Yu, Ming-Lung
Nguyen, Mindie H.
,
Funding for this research was provided by:
Gilead Sciences (IN-US-334-4309)
Article History
Received: 12 April 2019
Accepted: 26 July 2019
First Online: 28 August 2019
Compliance with ethical standards
:
: HT: Speaker for AbbVie and MSD. YCH: Research support from Gilead; advisory board for Gilead; speaker for Abbvie, BMS, Gilead, and Merck Sharp & Dohme. GW: Research support from Gilead; advisory board/consulting for Gilead; speaker for Abbott, Abbvie, BMS, Echosens, Furui, and Gilead. CHL: Research support from Abbvie, Gilead, and MSD; advisory board/consulting for Abbvie, Gilead, and MSD; speaker for Abbvie, Gilead, MSD, and Abbott. WLC: Advisory board for Gilead, Abbvie, MSD, BMS, PharmaEssentia. RC: Research support from Gilead. CYD: Advisory board for Abbvie; speaker for Abbvie, Merck, and Gilead. JHK: Research support from Gilead and BMS; advisory board/consulting for Gilead, Abbvie, BMS, and MSD; speaker for Gilead, Abbvie, MSD, and BMS. YU: Research support from Abbvie, Gilead, and Bayer. NF: Research support from Janssen Pharmaceutical K.K., Bristol-Myers Squibb, Gilead Sciences, Merck Sharp & Dohme, and Abbvie GK; speaker for Bristol-Myers Squibb, Gilead Sciences, Merck Sharp & Dohme, Torii Pharmaceutical Co., Ltd. and Roche Diagnostics K.K. MLY: Research support: Abbvie, BMS, Gilead, Torpedo and Merck; consultant for Abbvie, Abbott, Ascletis, BMS, Gilead, Merck, and PharmaEssentia; speaker for Abbvie, Abbott, Ascletis, BMS, Gilead, and Merck. YT: Research support from Chugai Pharmaceutical, Janssen, and the Japan Agency for Medical Research and Development (AMED); honoraria from Gilead. MHN: Research support from Janssen, Pfizer, Gilead, National Cancer Institute; BK Kee Foundation; advisory board/consulting for Novartis, Gilead, Janssen, Bayer, Eisai, Exact Sciences, Laboratory of Advanced Medicine. All other authors have no relevant conflict of interests to disclose.
: The study was conducted according to the Helsinki Declaration of 1975, as revised in 2008, and was approved by the Institutional Review Board at Stanford University, Stanford, California, USA and participating study centers.
Free to read: This content has been made available to all.